Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 192.05 SEK -1.01% Market Closed
Market Cap: kr52.3B

EV/OCF

12.5
Current
16%
Cheaper
vs 3-y average of 14.9

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
12.5
=
Enterprise Value
kr57.8B
/
Operating Cash Flow
kr4.6B

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
12.5
=
Enterprise Value
kr57.8B
/
Operating Cash Flow
kr4.6B

Valuation Scenarios

Getinge AB is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (14.9), the stock would be worth kr228.55 (19% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+27%
Average Upside
21%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 12.5 kr192.05
0%
3-Year Average 14.9 kr228.55
+19%
5-Year Average 14.6 kr224.39
+17%
Industry Average 15.2 kr233.26
+21%
Country Average 15.9 kr244.01
+27%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
SE
Getinge AB
STO:GETI B
52.8B SEK 12.5 22.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.2B USD 54.5 60
US
Abbott Laboratories
NYSE:ABT
158.3B USD 16.6 25.2
US
Stryker Corp
NYSE:SYK
125.3B USD 27 38.6
IE
Medtronic PLC
NYSE:MDT
106.9B USD 17.4 23.2
US
Boston Scientific Corp
NYSE:BSX
92B USD 22.3 31.8
DE
Siemens Healthineers AG
XETRA:SHL
40B EUR 15.6 18.9
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD 28.1 45.5
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.1B USD 38.5 42.6
US
Becton Dickinson and Co
NYSE:BDX
43.3B USD 17.5 24.7
US
Resmed Inc
NYSE:RMD
32B USD 16.2 21.6

Market Distribution

In line with most companies in Sweden
Percentile
39th
Based on 1 211 companies
39th percentile
12.5
Low
0.3 — 10.7
Typical Range
10.7 — 23.7
High
23.7 —
Distribution Statistics
Sweden
Min 0.3
30th Percentile 10.7
Median 15.9
70th Percentile 23.7
Max 9 494.9

Getinge AB
Glance View

Market Cap
52.3B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
222.84 SEK
Undervaluation 14%
Intrinsic Value
Price kr192.05
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett